| Product |
CAS |
Molecular formula |
More |
| N-ethyl-n-(2-(2-methoxypropan-2-yl)-1-((tetrahydro-2h-pyran-4-yl)methy |
849351-55-9 |
C25H32N4O6S |
More |
| 5-Bromo-n-[2-tert-butyl-1-(tetrahydro-2h-pyran-4-ylmethyl)-1h-benzimid |
849351-30-0 |
C23H28BrClN4O3S |
More |
| 5-Bromo-n-[2-tert-butyl-1-(cyclohexylmethyl)-1h-benzimidazol-5-yl]-6-c |
849349-02-6 |
C24H30BrClN4O2S |
More |
| N-[2-tert-butyl-1-(cyclohexylmethyl)-1h-benzimidazol-5-yl]-4-(ethylami |
849348-24-9 |
C27H38N4O2S |
More |
| (R)-3-piperidinone |
74279-87-1 |
C5H9NO |
More |
| (S)-3-piperidinone |
74279-88-2 |
C5H9NO |
More |
| 3-Piperidinone hydrobromide |
1188263-79-7 |
C5H9NO.HBR |
More |
| 3-(2-Phenylethyl)-4,5-dihydro-1h-pyrazol-5-one |
264208-83-5 |
C11H12N2O |
More |
| 5-Hydroxy-n-{3-methyl-4-[(6-methylpyridin-3-yl)oxy]phenyl}quinazolin-4 |
871019-20-4 |
C21H18N4O2 |
More |
| (4-Acetylamino-2-methyl-1h-indol-1-yl)acetic acid |
959619-21-7 |
C13H14N2O3 |
More |
| 4-(3-Chloro-2-fluoroanilino)-7-methoxy-6-[(1-methylpiperidin-4-yl)oxy] |
612500-80-8 |
C21H22ClFN4O2 |
More |
| 4-(3-Chloro-2-fluoroanilino)-7-methoxy-6-[(1-methylpiperidin-4-yl)meth |
612500-81-9 |
C22H24ClFN4O2 |
More |
| 4-(3-Chloro-2-fluoroanilino)-7-methoxy-6-[(piperidin-4-yl)methoxy]quin |
612500-79-5 |
C21H22ClFN4O2 |
More |
| 4-(3-Chloro-2-fluoroanilino)-7-methoxy-6-{[1-(2-methoxyethyl)piperidin |
612500-83-1 |
C23H26ClFN4O3 |
More |
| 4-(3-Chloro-2-fluoroanilino)-6-{[1-(methylsulfonyl)piperidin-4-yl]oxy} |
612500-85-3 |
C21H22ClFN4O4S |
More |
| 6-{[1-(Carbamoylmethyl)piperidin-4-yl]oxy}-4-(3-chloro-2-fluoroanilino |
612500-87-5 |
C22H23ClFN5O3 |
More |
| 6-{[(1-Tert-butoxycarbonyl)piperidin-4-yl]methoxy}-4-(3-chloro-2-fluor |
612501-82-3 |
C26H30ClFN4O4 |
More |
| N-cyclopropyl-3-(6-hydroxy-4-oxoquinazolin-3(4h)-yl)-4-methylbenzamide |
851847-76-2 |
C19H17N3O3 |
More |
| N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3 |
851845-37-9 |
C24H27N5O2 |
More |
| N-cyclobutyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3( |
851845-38-0 |
C25H29N5O2 |
More |
